Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
02/24/1993 | EP0528586A1 Inhibiting osteoclast-mediated bone resorption using aminoalkyl-substituted phenyl derivatives |
02/23/1993 | US5189212 Used in estrogen replacement therapy like menopause, osteoporosis therapy, prevention of excessive hair growth of body and infertility |
02/16/1993 | CA1313622C Pharmaceutical composition containing 17.beta.oestradiol and desogestr el |
02/10/1993 | CA2088518A1 Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
02/10/1993 | CA2075612A1 Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
02/02/1993 | US5183814 Selective oestrogen therapy for perimenopausal or postmenopausal conditions |
01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
01/20/1993 | EP0359739B1 Tranforming growth factor-beta |
01/13/1993 | EP0522576A2 Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use |
01/13/1993 | EP0522080A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
01/12/1993 | US5179110 Adrenergic stimulants; antiulcer agents, bronchodilators, treatment of diarrhea, glaucoma, osteoporisis, prostate, diabetes, migraine |
01/09/1993 | WO1993000921A1 Remedy for osteoporosis |
01/09/1993 | CA2090453A1 Remedy for osteoporosis |
01/07/1993 | WO1993000432A1 Bmp-9 compositions |
01/07/1993 | WO1993000348A1 Dimethylamino-hydroxy-alkan diphosphonic acids and pharmaceutical compositions containing them |
01/07/1993 | WO1993000050A1 Pharmaceutical formulations of osteogenic proteins |
01/07/1993 | DE4120990A1 Verfahren zur herstellung von diacetylrhein Process for the preparation of diacetylrhein |
01/07/1993 | CA2112250A1 Dimethylamino-hydroxy-alkan diphosphonic acids and pharmaceutical compositions containing them |
01/02/1993 | CA2072834A1 Ketone derivatives |
12/30/1992 | EP0520573A1 Cyclic imide derivatives |
12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
12/30/1992 | EP0520414A1 Process for the preparation of diacetylrhein |
12/30/1992 | CN1067427A Pyrazolopyridine compound and processes for preparation thereof |
12/28/1992 | CA2072551A1 Cyclic imide derivatives |
12/26/1992 | WO1993000322A1 Method of preparing diacetyl rhein |
12/23/1992 | WO1992022294A1 Immunomodulatory azaspiranes |
12/23/1992 | CA2110577A1 Immunomodulatory azaspiranes |
12/15/1992 | CA1311483C 5-pyrazolylcarbonyl- and 5-pyrazolyvinyl-phenoxy acetic acid derivatives and processes for preparing the same |
12/10/1992 | WO1992021379A1 Radiolabeled metal-binding protein for the treatment of arthritis |
12/10/1992 | WO1992021365A1 Therapeutic compositions for osteoinduction |
12/10/1992 | WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
12/10/1992 | WO1992019617A3 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
12/09/1992 | EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof |
12/06/1992 | WO1992021369A1 Synthetic calcitonin peptides |
12/06/1992 | CA2088922A1 Synthetic calcitonin peptides |
12/02/1992 | EP0516069A1 Leukotriene B4 antagonist |
12/01/1992 | CA2069667A1 Leukotriene b4 antagonist |
11/26/1992 | WO1992020371A1 Targeted delivery of bone growth factors |
11/26/1992 | WO1992017446A3 Pyridazinone acetic acids aldose reductase inhibitors |
11/25/1992 | EP0515228A2 Essential pure human parathyroid hormone |
11/25/1992 | EP0514720A2 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
11/19/1992 | EP0514130A2 Bone acidic glycoprotein (BAG-75) for inhibiting bone resorption |
11/19/1992 | EP0513387A1 Active oxygen inhibitor |
11/19/1992 | EP0513334A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-$g(b) FOR BONE REPAIR |
11/17/1992 | US5164368 Treatment for osteoporosis using growth hormone releasing factor (grf) in combination with parathyroid hormone (pth) |
11/14/1992 | CA2068389A1 Method for inhibiting bone resorption |
11/12/1992 | WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
11/12/1992 | WO1992019617A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/12/1992 | WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
11/12/1992 | WO1992017426A3 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
11/12/1992 | CA2108029A1 Glycam-1(sgp 50), a selectin ligand |
11/11/1992 | EP0512844A1 Targeted delivery of bone growth factors |
11/11/1992 | EP0512400A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/11/1992 | CA2102808A1 Targeted delivery of bone growth factors |
11/05/1992 | WO1992019628A1 Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them |
11/05/1992 | DE4114586A1 Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung Medicines containing azacyclodiphosphonsaeurederivate new azacyclodiphosphonsaeurederivate and procedures for their production |
11/05/1992 | CA2109318A1 Medicaments containing azacyclodiphosphonic acid derivatives, new azacyclodiphosphonic acid derivatives, as well as processes for their preparation |
10/29/1992 | WO1992018150A1 Mhc conjugates useful in ameliorating autoimmunity |
10/29/1992 | WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method |
10/21/1992 | EP0509317A2 Use of droloxifene in the treatment of bone diseases |
10/15/1992 | WO1992017482A1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof |
10/15/1992 | CA2107892A1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof |
10/14/1992 | CN1065269A Pyridazinone acetic acids |
10/06/1992 | US5153308 S-sulfonated calcitonin derivatives |
10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
10/01/1992 | WO1992016496A1 N-[[4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections |
09/30/1992 | CN1064813A Methods and compositions for treatment and repair of defects or lesions in cartilage |
09/29/1992 | WO1992017446A2 Pyridazinone acetic acids aldose reductase inhibitors |
09/29/1992 | US5151274 Calcium and trace mineral supplements |
09/29/1992 | CA2107104A1 Pyridazinone acetic acids as aldose reductase inhibitors |
09/27/1992 | WO1992017426A2 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
09/27/1992 | CA2105158A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
09/23/1992 | EP0505058A1 Thienopyridine derivatives and pharmaceutical compositions containing them |
09/23/1992 | EP0504799A1 Mixted pyridine-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation, their use as well as medicaments based on these compounds |
09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
09/19/1992 | CA2063177A1 Mixed pyridine-2,4- and -2,5-dicarboxamides, a process for preparing them, the use thereof and pharmaceuticals based on these compounds |
09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
09/03/1992 | WO1992014462A1 Cytokine inhibitors |
09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
08/27/1992 | WO1992014474A1 Methods for the treatment of osteoporosis |
08/20/1992 | WO1992013864A1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
08/20/1992 | WO1992013565A1 Growth factor containing matrix for the treatment of cartilage lesions |
08/19/1992 | CN1063685A Calcium uptake inhibitors |
08/14/1992 | WO1992014725A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
08/14/1992 | CA2101160A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
08/12/1992 | EP0498665A1 Hydroxamic acids derivatives, process for their preparation and use thereof |
08/11/1992 | US5137887 Salts of optically active 4-hydroxy-8(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo(1,5-a)-1,3,5- triazines and a process for production thereof |
08/08/1992 | WO1992013831A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
08/08/1992 | CA2100661A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
08/05/1992 | CN1017708B Method for preparation of pyrazolotriazine compounds |
07/29/1992 | EP0496520A1 Novel bone acting agents |
07/28/1992 | US5134159 Skin disorders |
07/28/1992 | US5133956 Radiolabeled metal-binding protein for the treatment of arthritis |
07/23/1992 | CA2059421A1 Bone acting agents |